L01BC Pyrimidine analogues, antineoplastic antimetabolites
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01BC Pyrimidine analogues, antineoplastic antimetabolites
Medicines by ATC code L01BC Pyrimidine analogues, antineoplastic antimetabolites
- Teysuno Patient leaflet Summary of medicine characteristics
- Azacitidine Accord Patient leaflet Summary of medicine characteristics
- Lonsurf Patient leaflet Summary of medicine characteristics
- Capecitabine Accord Patient leaflet Summary of medicine characteristics
- Azacitidine betapharm Patient leaflet Summary of medicine characteristics
- Vidaza Patient leaflet Summary of medicine characteristics
- Capecitabine Teva Patient leaflet Summary of medicine characteristics
- Xeloda Patient leaflet Summary of medicine characteristics
- Azacitidine Mylan Patient leaflet Summary of medicine characteristics
- Onureg Patient leaflet Summary of medicine characteristics
- Azacitidine Celgene Patient leaflet Summary of medicine characteristics
- Dacogen Patient leaflet Summary of medicine characteristics
- Ecansya (previously Capecitabine Krka) Patient leaflet Summary of medicine characteristics
- Capecitabine Medac Patient leaflet Summary of medicine characteristics
- DepoCyte Patient leaflet
- Capecitabine SUN Patient leaflet Summary of medicine characteristics
Other names of the ATC group
- Czech: L01BC Analogy pyrimidinu
- French: L01BC analogues de la pyrimidine
- German: L01BC Pyrimidin-Analoga
- Spanish: L01BC ANALOGOS DE PIRIMIDINAS (ANTINEOPLASICOS)
- German: L01BC Pyrimidin-Analoga
- Italian: L01BC ANALOGHI DELLA PIRIMIDINA
- Polish: L01BC Analogi pirymidyn
- Turkish: L01BC Pirimidin analogları, antineoplastik antimetabolitler
- Portuguese (Brazil): L01BC Análogos da pirimidina